Neurocrine’s Ingrezza, approved…
Neurocrine’s Ingrezza, approved to treat certain uncontrolled movements, failed to [...]
William Blair has hand-picked its…
William Blair has hand-picked its top five stock recommendations for [...]
Drug pricing, layoffs, personnel…
Drug pricing, layoffs, personnel moves and other topics drove reader [...]
Hope Biosciences has linked its…
Hope Biosciences has linked its stem cell therapy candidate to [...]
Pharma giant AstraZeneca extended…
Pharma giant AstraZeneca extended its supply deal with Michigan-based medical [...]
Despite a year of trade tensions,…
Despite a year of trade tensions, national security strictures and [...]
Six people, including a former…
Six people, including a former employee of investment bank Citigroup’s [...]
CMS’ Innovation Center has…
CMS’ Innovation Center has released two new drug pricing models [...]
Boehringer’s Jascayd can now crack…
Boehringer’s Jascayd can now crack open the rare progressive pulmonary [...]
Slated for a Dec. 26 decision on…
Slated for a Dec. 26 decision on Cytokinetics’ aficamten, the [...]